GeneCentric Therapeutics Acquires Select ImmunoGenomics to propel precision oncology through RNA technologies Learn more
  • About Us
  • Approach
  • Profiler Pipeline
  • Collaborations
  • News & Events
  • Contact

Lung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes Demonstrate Significant Differences in Tumor Immune Landscape.

urosm23 | March 21, 2017

Faruki H, Mayhew GM, Serody JS, Hayes DN, Perou CM, Lai-Goldman M. Lung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes Demonstrate Significant Differences in Tumor Immune Landscape. Jrnl Thoracic Oncology. 2017 Mar 21. pii: S1556-0864(17)30214-9. doi: 10.1016/j.jtho.2017.03.010. Link

Immune Cell Activation among Lung Adenocarcinoma and Squamous Cell Carcinoma Subtypes and CD274(PD-L1) Expression.
Differences in BRCAness/PARP Inhibitor Response Signatures and Homologous Recombination Gene Expression Across Lung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes

GeneCentric Therapeutics. All rights reserved.

CONNECT WITH US

info@genecentric.com
(919) 973-6544

QUICK LINKS

Careers
Contact us

Sitemap

  • About Us
  • Approach
  • Profiler Pipeline
  • Collaborations
  • News & Events
  • Contact